INTRODUCTION
============

Focal cortical dysplasia (FCD) is a subgroup of malformations of cortical development characterized by abnormal cortical lamination, neuronal migration, and differentiation. It was first reported from pathological specimens obtained in ten patients with drug resistant epilepsy \[[@b50-jkns-2019-0005]\]. Over the past decade, several classifications of FCD have been proposed \[[@b2-jkns-2019-0005],[@b39-jkns-2019-0005]\]. In 2011, the International League Against Epilepsy Task Force proposed a new consensus classification based on histopathological features to yield consistent interobserver and intraobserver reliability \[[@b5-jkns-2019-0005]\].

FCD has a high epileptogenic potential, and is often associated with drug-resistant epilepsy. It is the most common cause of intractable focal epilepsy in children undergoing epilepsy surgery \[[@b20-jkns-2019-0005],[@b32-jkns-2019-0005]\]. The primary goal of epilepsy surgery for intractable epilepsy is to achieve seizure freedom and eliminate adverse consequences of continuing antiepileptic drug (AED) treatment. When children achieve seizure freedom after successful epilepsy surgery, withdrawal of AEDs is generally considered. After assessing the benefits of AED discontinuation and the risk of seizure recurrence after withdrawal, clinicians decide whether and when to stop the AEDs. For young children, additional objective is to optimize neuropsychological development and improve the quality of life after surgery \[[@b13-jkns-2019-0005]\].

In this article, we focused on the seizure and cognitive outcomes of epilepsy surgery in pediatric FCD series. Moreover, we reviewed the prognostic factors for favorable outcome after epilepsy surgery.

SEIZURE OUTCOME
===============

Seizure outcomes after epilepsy surgery has been improved over time with the advancement of preoperative diagnostic methods and surgical techniques \[[@b47-jkns-2019-0005],[@b54-jkns-2019-0005]\]. The overall seizure-free outcome after surgery ranges from 50 to 75% \[[@b7-jkns-2019-0005],[@b9-jkns-2019-0005],[@b12-jkns-2019-0005],[@b29-jkns-2019-0005]\]. Details of the selected surgical series are shown in [Table 1](#t1-jkns-2019-0005){ref-type="table"}. Seizure outcomes after surgery are dependent on a number of factors including pathologic etiologies, extent of lesion, and types of surgery. Series that analyzed mostly short term follow-up after surgery presented better seizure outcome \[[@b35-jkns-2019-0005],[@b52-jkns-2019-0005]\]. These surgical series are associated with a decrease in seizure-freedom with postoperative time \[[@b28-jkns-2019-0005],[@b34-jkns-2019-0005]\]. Some studies reported that seizure outcome at least 2 years after surgery remained stable as long-term outcome \[[@b15-jkns-2019-0005],[@b19-jkns-2019-0005],[@b45-jkns-2019-0005]\]. Therefore, it can be considered that a 2-year postoperative outcome may reflect the long-term seizure outcome.

Seizure outcomes of the two large pediatric surgical series are further discussed here. One of the largest pediatric series analyzed the outcome of 113 children who underwent surgery between 1996 and 2004 \[[@b12-jkns-2019-0005]\]. The mean age at surgery was 8.8 years. Pathologic etiologies include not only FCD, but also dual pathologies such as glio-neuronal tumors or mesial temporal sclerosis. The majority (96%) had abnormal brain magnetic resonance imaging (MRI). At 55 months after the mean postoperative follow-up, 68% were categorized as Engel's class I, with 60% being seizure free (Engel's classes Ia and Ic). They reported that focal lesion on MRI, older age at seizure onset, complete resection, unilobar temporal resection, and a glioneuronal tumor had better surgical outcome.

Another series studied the surgical outcome of 149 patients (144 patients were \<20 years and five adult patients) with a mild malformation of cortical development (mMCD) or FCD \[[@b29-jkns-2019-0005]\]. Surgery was performed between 1986 and 2006. Of these 149 patients, 29 patients had mMCD, 58 patients were classified as FCD type I, and 52 patients as FCD types II. At 2 years follow-up, 55% were classified as Engel's class I. With regard to long-term seizure outcome, 113 patients were followed-up for at least 5 years after surgery, and 75% of them remained stable seizure status after the second postoperative year. This study mainly included children with histologically proven mMCD/FCD, and demonstrated that complete resection is the most important predictive prognostic factor for surgical outcome.

PROGNOSTIC FACTORS OF FAVORABLE OUTCOME
=======================================

Several prognostic factors related to surgical outcome have been proposed. It is crucial to select the best surgical candidates based on predictors of favorable surgical outcome. In a meta-analysis of FCD surgical series, complete resection, severe type of histopathology, detection of MRI lesion, and temporal location of the surgery were found to be important prognostic factors \[[@b8-jkns-2019-0005],[@b44-jkns-2019-0005]\]. However, the heterogeneity of patient populations, types of surgery, and pathologic etiologies between studies may account for the inconsistency in the proposed prognostic factors across various studies.

Complete resection is widely accepted to be the most important prognostic factor for seizure freedom after surgery \[[@b9-jkns-2019-0005],[@b10-jkns-2019-0005],[@b12-jkns-2019-0005],[@b15-jkns-2019-0005],[@b18-jkns-2019-0005],[@b19-jkns-2019-0005],[@b25-jkns-2019-0005],[@b26-jkns-2019-0005],[@b29-jkns-2019-0005],[@b35-jkns-2019-0005]\]. Complete resection is generally defined as complete removal of the lesion on neuroimaging or the interictal and ictal onset zones on intracranial electrode recording. Patients with complete resection achieved 60--70% chance of becoming seizure free, while those with incomplete resection only achieved 14--22% \[[@b9-jkns-2019-0005],[@b26-jkns-2019-0005],[@b29-jkns-2019-0005]\]. Complete resection of the visible lesions (lesional zone) and the epileptogenic zone would increase the likelihood of successful surgical outcomes. It is difficult to assert that resection of the visible lesion is sufficiently includes the epileptogenic zone. Indeed, the epileptogenic zone may be organized as the focal lesional site or as a more complex network extending beyond the lesion \[[@b36-jkns-2019-0005],[@b46-jkns-2019-0005]\]. To delineate epileptogenic zone, patients with normal MRI or poorly localizing electroencephalography undergo intracranial electrode monitoring, electrocorticography, or stereo-electroencephalography. In addition, a resection of the seizure onset zone, which were determined by high-frequency oscillations or lowvoltage fast activities, resulted in a favorable seizure outcome in pediatric FCD \[[@b1-jkns-2019-0005],[@b17-jkns-2019-0005],[@b31-jkns-2019-0005]\]. The leading cause of incomplete resection was the overlap between the epileptogenic zone and the eloquent cortex \[[@b18-jkns-2019-0005],[@b21-jkns-2019-0005],[@b30-jkns-2019-0005],[@b33-jkns-2019-0005]\]. When the epileptogenic zone overlaps with eloquent cortex, multiple subpial transections (MST) can be considered; however, the efficacy of MST in epilepsy surgery has not yet been fully elucidated \[[@b3-jkns-2019-0005]\].

Both pediatric and adults surgical series demonstrated that severe dysplasia usually yields a more favorable outcomes compared with mild cortical dysplasia \[[@b23-jkns-2019-0005],[@b25-jkns-2019-0005],[@b27-jkns-2019-0005],[@b49-jkns-2019-0005],[@b52-jkns-2019-0005],[@b55-jkns-2019-0005]\]. In a series of 40 pediatric FCD (24 FCD type I and 16 FCD type II), seizure freedom was achieved in 75% of FCD type II patients, whereas only 21% of FCD type I patients \[[@b30-jkns-2019-0005]\]. Conversely, some studies failed to identify any significant differences between the seizure outcome and severity of histopathology \[[@b15-jkns-2019-0005],[@b35-jkns-2019-0005],[@b57-jkns-2019-0005]\]. Compared with FCD, glio-neuronal tumors are known to have greater favorable outcomes \[[@b12-jkns-2019-0005],[@b14-jkns-2019-0005],[@b37-jkns-2019-0005],[@b52-jkns-2019-0005]\]. Furthermore, glioneuronal tumors associated with FCDs (FCD IIIa) showed excellent outcome compared with FCD type I, which was comparable to solitary tumors \[[@b11-jkns-2019-0005]\].

Cohort studies evaluating predictors of surgical outcome reported better outcomes in patients with demonstrated MRI lesions than in those without relevant MRI abnormalities \[[@b9-jkns-2019-0005],[@b12-jkns-2019-0005],[@b23-jkns-2019-0005],[@b40-jkns-2019-0005]\]. A meta-analysis in various surgical groups of patients showed that patients with lesions on MRI had a 2.5 times higher chance of seizure freedom after surgery (odds ratio, 2.5; 95% confidence interval, 2.1--3.0; *p*\<0.001) \[[@b51-jkns-2019-0005]\]. The same observation has been reported in patients with FCD \[[@b44-jkns-2019-0005]\]. Constellation of MRI findings is diagnostic for FCD in patients with intractable epilepsy. However, MRI findings can often be subtle and difficult to detect, especially for patients with FCD type I. In a previous study, about 20% of patients with FCD had normal MRI scans \[[@b32-jkns-2019-0005]\]. A structural lesion on MRI is likely to be co-located with the epileptogenic cortex. Furthermore, a discrete lesion on MRI may provide substantial information to localize the epileptogenic zone and serve as a marker of the resection area allowing a more effective resection. However, even in the absence of MRI lesion, it may be worthwhile to consider epilepsy surgery in patients with intractable focal epilepsy. Multimodal integrative presurgical evaluation may lead to a good outcome in patients with intractable focal epilepsy, even without demonstrable lesion on MRI \[[@b24-jkns-2019-0005]\].

In both pediatric and adult FCD series, the seizure outcome of temporal lobe resection was better than that of extratemporal resection \[[@b8-jkns-2019-0005],[@b12-jkns-2019-0005],[@b22-jkns-2019-0005],[@b35-jkns-2019-0005],[@b44-jkns-2019-0005]\]. Better localization of the epileptogenic zone and chances of combined dual pathology, such as hippocampal sclerosis, might contribute to improve seizure outcome in temporal lobe resection. Moreover, in temporal lobe resection, there is no need to consider sparing the eloquent areas.

The need for intracranial monitoring was associated with poor outcome \[[@b6-jkns-2019-0005]\]. Generally intracranial monitoring is performed when there is uncertainty in the location and extent of the epileptogenic zone. Therefore, poor localization of the epileptogenic zone could be a reason for intracranial monitoring which ultimately results in poor surgical outcome.

COGNITIVE OUTCOME
=================

Children with FCD frequently have combined developmental and cognitive dysfunction \[[@b30-jkns-2019-0005],[@b32-jkns-2019-0005],[@b49-jkns-2019-0005],[@b55-jkns-2019-0005]\]. Another important aim of epilepsy surgery in children is to improve the overall cognitive outcome. In a study of infants treated surgically for catastrophic epilepsy, Wyllie observed a marked catch-up development in those with at least 50% reduction in seizures \[[@b56-jkns-2019-0005]\]. In a series of 42 children who underwent temporal resection for intractable epilepsy caused by hippocampal sclerosis or dysembryoplastic neuroepithelial tumors, a statistically significant improvement of the full scale intelligence quotients was observed \[[@b48-jkns-2019-0005]\]. However, the improvement of cognitive function is not guaranteed after surgery in all patients. A study evaluating the cognitive outcome after epilepsy surgery in preschool children showed that only a few patients gained cognitive improvement after surgery \[[@b16-jkns-2019-0005]\]. They reported that patients who achieved seizure-free, shorter duration of epilepsy, and a low preoperative developmental level showed cognitive improvement following surgery. However, to the best of our knowledge, studies evaluating the cognitive outcome after epilepsy surgery for FCD are limited ([Table 2](#t2-jkns-2019-0005){ref-type="table"}). A study of 40 children with FCD type II reported that 37.5% of children showed an improvement after surgery \[[@b42-jkns-2019-0005]\]. However, in other pediatric series, a stabilization of cognitive function, rather than a marked improvement, after successful surgery was demonstrated \[[@b41-jkns-2019-0005],[@b43-jkns-2019-0005]\]. Therefore, cognitive improvement is not guaranteed in all patients after effective epilepsy surgery. Nonetheless, cognitive improvement, at least stabilized cognitive function, is possible after surgery.

The fact that early onset and long duration of epilepsy may be followed by cognitive deterioration suggests a window of vulnerability for irreversible decline of cognition \[[@b4-jkns-2019-0005],[@b38-jkns-2019-0005],[@b53-jkns-2019-0005]\]. Some pediatric FCD series demonstrated the better cognitive outcomes after surgery in patients with shorter epilepsy duration \[[@b7-jkns-2019-0005],[@b41-jkns-2019-0005]\]. In contrast, other study opposed that epilepsy duration did not appear to inf luence cognitive outcome after surgery \[[@b42-jkns-2019-0005]\]. Nevertheless, to minimize the detrimental effects of uncontrolled seizure, early surgical intervention and cessation of seizure activity are important for children with intractable epilepsy.

CONCLUSION
==========

Focal cortical dysplasia is a major cause of focal intractable epilepsy and epilepsy surgery in childhood. The efficacy of epilepsy surgery is dependent on the ability to precisely localize and resect the epileptogenic zone. Among the several prognostic factors, complete resection of the epileptogenic zone is the most powerful predictor for favorable seizure outcome. We observed cognitive improvement or stabilization after surgery in children with FCD. However, more studies to support early surgical intervention for a better cognitive outcome will be required.

No potential conflict of interest relevant to this article was reported.

INFORMED CONSENT

This type of study does not require informed consent.

###### 

Cohort characteristics and outcomes after epilepsy surgery in children with focal cortical dysplasia/malformation of cortical development

  Study                                                    No. of patients     Mean age at surgery (years)   Pathology                                                Lesion on MRI          Mean follow-up period                        Engel I outcome                 Predictors of favorable
  -------------------------------------------------------- ------------------- ----------------------------- -------------------------------------------------------- ---------------------- -------------------------------------------- ------------------------------- ----------------------------------------------------------------------------------------------------------------------
  Kloss et al. \[[@b26-jkns-2019-0005]\] (2002)            68 (P)              5.9                           FCDⅠ 60%, FCDⅡ 40%; tumors and dual pathology excluded   95%                    2 years or more                              50%                             Complete resection
  Hudgins et al. \[[@b23-jkns-2019-0005]\] (2005)          15 (P)              7.8                           FCD with dual pathologies                                60%                    4 years                                      60%                             MRI visible lesion, higher pathologic severity
  Cossu et al. \[[@b12-jkns-2019-0005]\] (2008)            113 (P)             8.8                           FCD/MCD with tumors and other pathologies                96%                    55.1 months                                  68%                             Unifocal lesion on MRI, older age at seizure, complete resection, unilobar temporal resection, glial-neuronal tumors
  Krsek et al. \[[@b29-jkns-2019-0005]\] (2009)            149 (5 A & 144 P)   NR                            FCD histology tumors and dual pathology excluded         71/108 (66%)           6.5 years; 113 with 5-year 55 with 10-year   55%                             Complete resection
  Krsek et al. \[[@b30-jkns-2019-0005]\] (2009)            40 (P)              7.0                           FCD/MCD with HS; tumors and dual pathology excluded      90%                    4.39 years                                   35%                             Complete resection, FCD typeⅡ
  Phi et al. \[[@b40-jkns-2019-0005]\] (2010)              41 (P)              9.0                           FCD histology                                            54%                    73 months                                    49% at 1 year; 44% at 2 years   MRI visible lesion, complete resection
  Teutonico et al. \[[@b52-jkns-2019-0005]\] (2013)        120 (P)             10.0                          FCD/MCD with tumor and cryptogenic lesions               80%                    57 months; 98 patients at least 2 years      77.5%                           Age of onset of infantile spasms (\>24 months), hypomotor seizures, phasic postictal deficit, FCD typeⅡ
  Mühlebner et al. \[[@b35-jkns-2019-0005]\] (2014)        60 (P)              8                             FCD/MCD pathology                                        100%                   4.4 years                                    78% at 1 year; 72% at 4 years   Temporal location, hemispherotomies, absence of interictal spikes on postsurgical EEG, complete resection
  Ramírez-Molina et al. \[[@b42-jkns-2019-0005]\] (2017)   106 (66 A & 40 P)   NR                            Only FCD typeⅡ                                           97.5% (P), 84.8% (A)   1 year or more                               75% (P); 71% (A)                NR
  Choi et al. \[[@b9-jkns-2019-0005]\] (2018)              58 (P)              9.4                           FCD pathology                                            82.8%                  5.1 years                                    62% at 1 year; 57% at 2 year    MRI visible lesion, complete resection
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###### 

Cognitive outcome after epilepsy surgery in children with focal cortical dysplasia/malformation of cortical development

  Study                                                                             No. of patients     Inclusion criteria                                                                                                                        Comments
  --------------------------------------------------------------------------------- ------------------- ----------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------
  Roulet-Perez et al. \[[@b43-jkns-2019-0005]\] (2010)                              11 (P)              Early refractory epilepsy                                                                                                                 Only child with FCD type llb showed developmental improvement.
  2 FCD type Ila, 4 FCD type Ilb^[\*](#tfn1-jkns-2019-0005){ref-type="table-fn"}^                                                                                                                                                                 
  Ramantani et al. \[[@b41-jkns-2019-0005]\] (2013)                                 30 (P)              Early refractory epilepsy                                                                                                                 Most of patients (93%) showed stabilized developmental trajectories rather than catch-up.
  Age at surgery under 3 years                                                                                                                                                                                                                    
  24 MCD, 6 glioneuronal tumor included                                                                                                                                                                                                           
  Chen et al. \[[@b7-jkns-2019-0005]\] (2014)                                       30 (P)              All FCD (1 FCD type Ia, 7 FCD type Ib, 7 FCD type IIa, 12 FCD type IIb, 3 FCD type III)^[†](#tfn2-jkns-2019-0005){ref-type="table-fn"}^   Early seizure onset without cognitive function deficit and early surgical intervention showed best cognitive outcome.
  Ramirez-Molina et al. \[[@b42-jkns-2019-0005]\] (2017)                            106 (66 A & 40 P)   Only FCD type II^[†](#tfn2-jkns-2019-0005){ref-type="table-fn"}^                                                                          Both groups showed cognitive improvement after surgery. Age at surgery (duration of epilepsy) did not affect cognitive outcome.

Pathology based on Palmini classification \[[@b39-jkns-2019-0005]\] : FCD type IIa (dysmorphic neurons without balloon cells), and FCD type IIb (dysmorphic neurons and balloon cells).

Pathology based on the new ILAE classification \[[@b5-jkns-2019-0005]\] : FCD type Ia (abnormal radial cortical lamination), FCD type Ib (abnormal tangential cortical lamination), FCD type IIa (dysmorphic neurons without balloon cells), FCD type IIb (dysmorphic neurons and balloon cells), FCD type III (FCD with another principal lesions).

P : pediatrics, FCD : focal cortical dysplasia, A : adults, MCD : malformation of cortical development
